Current and future antithrombotic agents in children.

about

Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study.UNBLOCK: an open-label, dose-finding, pharmacokinetic and safety study of bivalirudin in children with deep vein thrombosis.

P2860

Q33394891-2D3E2CC5-C669-4B20-82F9-2A28EA4A9F47 Q46069198-EBB674A1-364D-4898-A867-288E55FC593D

P2860

Current and future antithrombotic agents in children.

Item

http://www.wikidata.org/entity/Q35821894

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Current and future antithrombotic agents in children.

@ast

Current and future antithrombotic agents in children.

@en

type

Item

label

Current and future antithrombotic agents in children.

@ast

Current and future antithrombotic agents in children.

@en

prefLabel

Current and future antithrombotic agents in children.

@ast

Current and future antithrombotic agents in children.

@en

P1476

Current and future antithrombotic agents in children.

@en

P2093

Guy Young

http://www.w3.org/2001/XMLSchema#string

P2860

Ximelagatran: a new oral anticoagulant

Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor.

Heparin-induced thrombocytopenia in pediatrics.

Lepirudin anticoagulation for heparin-induced thrombocytopenia.

Low molecular weight heparin in children.

Argatroban therapy does not generate antibodies that alter its anticoagulant activity in patients with heparin-induced thrombocytopenia.

Hirudin in heparin-induced thrombocytopenia.

Anticoagulation with recombinant hirudin and danaparoid sodium in pediatric patients.

Argatroban use during pediatric interventional cardiac catheterization.

Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII.

P304

523-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.2.4.523

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15225112

http://www.w3.org/2001/XMLSchema#string

Current and future antithrombotic agents in children.

about

P2860

P2860

Current and future antithrombotic agents in children.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698